Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean-Marie Ferland is active.

Publication


Featured researches published by Jean-Marie Ferland.


Tetrahedron Letters | 1989

Photolabile p-methoxyphenacyloxycarbonyl group for the protection of amines

George Church; Jean-Marie Ferland; Jean Gauthier

Abstract P-Methoxyphenacyloxycarbonyl (Phenoc) is a new photolabile protective group for amines. Various phenacyl urethanes, i.e. Phenoc protected amines, have been prepared. An application of the group in peptide synthesis is reported.


Bioorganic & Medicinal Chemistry | 1994

Herpes simplex virus ribonucleotide reductase subunit association inhibitors: the effect and conformation of β-alkylated aspartic acid derivatives

Neil Moss; Robert Deziel; Jean-Marie Ferland; Sylvie Goulet; Paul-James Jones; Scott F. Leonardo; T. Phil Pitner; Raymond Plante

Incorporating beta-alkylated aspartic acid derivatives into herpes simplex virus ribonucleotide reductase subunit association inhibitors can improve inhibitor potency up to 50 times over the corresponding inhibitors containing an unsubstituted aspartic acid. A combination of NMR studies, conformational analysis, and molecular mechanics calculations suggests that the beta-alkyl group improves inhibitor potency by favoring the bioactive conformation of the critical aspartic acid carboxyl group. Further support for this hypothesis is provided by a potent conformationally restricted aspartic acid derivative in which the carboxyl group is locked in the putative bioactive conformation.


Organic Letters | 2004

Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans

Anne-Marie Faucher; Murray D. Bailey; Pierre L. Beaulieu; Christian Brochu; Jean-Simon Duceppe; Jean-Marie Ferland; Elise Ghiro; Vida Gorys; Ted Halmos; Stephen H. Kawai; Martin Poirier; Bruno Simoneau; and Youla S. Tsantrizos; Montse Llinas-Brunet


Journal of Organic Chemistry | 2004

Potent inhibitors of the hepatitis C virus NS3 protease: Design and synthesis of macrocyclic substrate-based β-strand mimics

Nathalie Goudreau; Christian Brochu; Dale R. Cameron; Jean-Simon Duceppe; Anne-Marie Faucher; Jean-Marie Ferland; Chantal Grand-Maitre; Martin Poirier; Bruno Simoneau; Youla S. Tsantrizos


Journal of Organometallic Chemistry | 2006

Olefin ring-closing metathesis as a powerful tool in drug discovery and development – potent macrocyclic inhibitors of the hepatitis C virus NS3 protease

Youla S. Tsantrizos; Jean-Marie Ferland; Andrew McClory; Martin Poirier; Vittorio Farina; Nathan K. Yee; Xiao-Jun Wang; Nizar Haddad; Xudong Wei; Jinghua Xu; Li Zhang


Angewandte Chemie | 2004

Binding Mode Determination of Benzimidazole Inhibitors of the Hepatitis C Virus RNA Polymerase by a Structure and Dynamics Strategy

Steven R. LaPlante; Araz Jakalian; Yves Bousquet; Jean-Marie Ferland; James Gillard; Sylvain Lefebvre; Martin Poirier; Youla S. Tsantrizos; George Kukolj; Pierre L. Beaulieu


Journal of Organic Chemistry | 2005

RCM of Tripeptide Dienes Containing a Chiral Vinylcyclopropane Moiety: Impact of Different Ru-Based Catalysts on the Stereochemical Integrity of the Macrocyclic Products

Martin Poirier; Colette Boucher; Jean-Marie Ferland; Steve Laplante; Youla S. Tsantrizos


Journal of Medicinal Chemistry | 1996

Peptidomimetic Inhibitors of Herpes Simplex Virus Ribonucleotide Reductase with Improved in Vivo Antiviral Activity

Neil Moss; Pierre L. Beaulieu; Jean-Simon Duceppe; Jean-Marie Ferland; Michel Garneau; Jean Gauthier; Elise Ghiro; Sylvie Goulet; Ingrid Guse; Jorge Jaramillo; Montse Llinas-Brunet; Eric Malenfant; Raymond Plante; Martin Poirier; Francois Soucy; Dominik Wernic; Christiane Yoakim; Robert Deziel


Archive | 1998

Pyridones as src family sh2 domain inhibitors

Rajashekhar Betageri; Pierre L. Beaulieu; Montse Llinas-Brunet; Jean-Marie Ferland; Mario G. Cardozo; Neil Moss; Usha R. Patel; John R. Proudfoot


Journal of Medicinal Chemistry | 1995

Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase : a new class of antiviral agents

Neil Moss; Pierre L. Beaulieu; Jean-Simon Duceppe; Jean-Marie Ferland; Jean Gauthier; Elsie Ghiro; Sylvie Goulet; Louis Grenier; Montse Llinas-Brunet; Raymond Plante; Dominik Wernic; Robert Deziel

Collaboration


Dive into the Jean-Marie Ferland's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jean Gauthier

Université du Québec à Montréal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge